Cholangiocarcinoma — evolving concepts and therapeutic strategies

Ilyas, Sumera I., Khan, Shahid A., Hallemeier, Christopher L., Kelley, Robin K., Gores, Gregory J.·2018·Nature Reviews Clinical Oncology

DOI 10.1038/nrclinonc.2017.157

Cited by (1,001)

Items 701–800 of 1,001

Impact of perioperative blood transfusion on long-term survival in patients with different stages of perihilar cholangiocarcinoma treated with curative resection: A multicentre propensity score matching study
Zhi-Peng Liu, Zheng-Jun Cheng, Hai-Su Dai, Shi-Yun Zhong, Dong-Chu Zhao, Yi Gong, Jing-Hua Zuo, Xiao-Yu Che, Wei-Yue Chen, Zi-Ran Wang et al. · 2022 · Frontiers in Oncology
Biliary Tract Cancer: Implicated Immune-Mediated Pathways and Their Associated Potential Targets
Noor-ul-Ain Tariq, Arndt Vogel, Mairead Geraldine McNamara, Juan W. Valle · 2018 · Oncology Research and Treatment
Photodynamic therapy of cancer of large duodenal papilla and extrahepatic bile ducts
Eugeny P. Stranadko, Alexey V. Baranov, V. A. Duvanskiy, Лобаков Александр Иванович, V. A. Morokhotov, Michail V. Riabov · 2020 · Biomedical Photonics
A prognostic systemic inflammation score (SIS) in patients with advanced intrahepatic cholangiocarcinoma
M. Maßmann, Jürgen Walter Treckmann, Peter M. Markus, Brigitte M. Schumacher, David Albers, Saskia C. Ting, Bastian Mende, Julius Röhrle, Isabel Virchow, Vivian Rosery et al. · 2022 · Journal of Cancer Research and Clinical Oncology
Preoperative prognostic nutritional index predicts short-term complications after radical resection of distal cholangiocarcinoma
Yulong He, Haoran Liu, Yuhu Ma, Jianlong Li, Jinduo Zhang, Yanxian Ren, Chunlu Dong, Bing Bai, Yong Zhang, Yanyan Lin et al. · 2023 · Frontiers in Surgery
Relevance of Bile Acids in Cholangiocarcinoma Pathogenesis: Critical Revision and Future Directions
Valentina Cossiga, Maria Guarino, Mario Capasso, Filomena Morisco · 2023 · Cells
Nuclear medicine radiomics in digestive system tumors: Concept, applications, challenges, and future perspectives
Wenpeng Huang, Zihao Tao, Muhsin H. Younis, Weibo Cai, Lei Kang · 2023 · Open Research (University of Surrey)
Tspan15‐ADAM10 signalling enhances cancer stem cell‐like properties and induces chemoresistance via Notch1 activation in ICC
Arihito Yoshizumi, Satoshi Kuboki, Tsukasa Takayashiki, Shigetsugu Takano, Ryosuke Takayanagi, Itaru Sonoda, Masayuki Ohtsuka · 2023 · Liver International
Factors influencing the diagnostic and prognostic values of circulating tumor cells in breast cancer: a meta-analysis of 8,935 patients
Hongfang Zhao, Luxuan Wang, Chuan Fang, Chunhui Li, Lijian Zhang · 2023 · Frontiers in Oncology
Human Vγ9Vδ2 T cell expansion and their cytotoxic responses against cholangiocarcinoma
Piamsiri Sawaisorn, Ahmed Gaballa, Kween Saimuang, Chaniya Leepiyasakulchai, Sakaorat Lertjuthaporn, Suradej Hongeng, Michael Uhlin, Kulachart Jangpatarapongsa · 2024 · Scientific Reports
Impact of sarcopenia on the short-term and long-term outcomes of intrahepatic cholangiocarcinoma undergoing hepatectomy: A multi-center study
Rizhao Li, Bo Chen, Ziyan Chen, Qing Su, Qikuan He, Jinhuan Yang, Puchuang Xu, Jiawei Hu, Yuepeng Jin, Zhiyuan Bo · 2024 · European Journal of Surgical Oncology
Anatomic Versus Non-anatomic Liver Resection for Intrahepatic Cholangiocarcinoma: A Systematic Review and Patient-Level Meta-Analysis
Giammauro Berardi, Luca Risi, Edoardo Maria Muttillo, Daniel Aliseda, Marco Colasanti, Giuseppe Maria Ettorre, Luca Viganò · 2024 · Annals of Surgical Oncology
Current advance in comprehensive management of hilar cholangiocarcinoma and navigation in surgery: non-systematic reviews
Man Luo, Jiapeng Yang, Kai Zhang, Ji Sun, Zhiyu Lu, Zhihao Wang, Yaowei Hu, Jianxin Zhai, Peng Xie, Tana Siqin et al. · 2024 · International Journal of Surgery
YBX1 is required for maintaining PD-L1 expression in intrahepatic cholangiocarcinoma by regulating STAT1 stability in an m5C-dependent manner
Xiangyi Sun, Bo Yu, Jia Yu, Yuan-Pei Wang, Xian-Bin Li, Ranran Sun, Xin Tian, Quancheng Kan · 2025 · Hepatobiliary & pancreatic diseases international
Molecular mechanisms and genetic features of cholangiocarcinoma: implications for targeted therapeutic strategies
Xiao Lu, Shoujia Xu, Zhe Deng, Minjun Wang, Fei Chen · 2025 · Precision Clinical Medicine
Segmentation of Pathological Features of Rat Bile Duct Carcinoma from Hyperspectral Images
Jiansheng Wang, Menghan Hu, Mei Zhou, Sun Li, Qingli Li · 2018 · International Congress on Image and Signal Processing (CISP)
Prognostic Nomogram That Predicts Overall Survival of Patients with Distal Cholangiocarcinoma After Pancreatoduodenectomy
Qiao Chen, Jiayi Li, Bao Jin, Xiangan Wu, Yue Xi Shi, Haifeng Xu, Yongchang Zheng, Yingyi Wang, Shunda Du, Xin Lü et al. · 2020 · Cancer Management and Research
Surgical Treatment for Intrahepatic, Peri-Hilar, and Distal Cholangiocarcinoma: 20-Single Institutional Year Experience
Ayah Istanbouli, Shreya Patel, Tariq Almerey, Zhuo Li, John Andrew Stauffer · 2021 · The American Surgeon
Fluoropyrimidine-based doublet chemotherapy as second-line treatment for advanced biliary tract cancer: a meta-analysis of ABC-06 and NIFTY
Alessandro Rizzo, Antonio Cusmai, Francesco Giovannelli, Silvana Acquafredda, Lucia Rinaldi, Andrea Misino, Gennaro Palmiotti · 2022 · Expert Review of Gastroenterology & Hepatology
Paracrine Interaction of Cholangiocellular Carcinoma with Cancer-Associated Fibroblasts and Schwann Cells Impact Cell Migration
Jan-Paul Gundlach, Jannik Kerber, Alexander Hendricks, Alexander Bernsmeier, Christine Halske, Christian Röder, Thomas Becker, Christoph Röcken, Felix Braun, Susanne Sebens et al. · 2022 · Journal of Clinical Medicine
Homologous Recombination Repair in Biliary Tract Cancers: A Prime Target for PARP Inhibition?
Chao Yin, Monika Kulasekaran, Tina Roy, Brennan James Decker, Sonja Alexander, Matthew L. Margolis, Reena C. Jha, Gary M. Kupfer, Aiwu Ruth He · 2022 · Cancers
Bone Mineral Density Is a Predictor of Mortality in Female Patients with Cholangiocellular Carcinoma Undergoing Palliative Treatment
Markus Sebastian Jördens, Linda Wittig, Christina Loberg, Lisa Heinrichs, Verena Keitel, Maximilian Franz Schulze-Hagen, Gerald Antoch, Wolfram Trudo Knoefel, Georg Fluegen, Sven Heiko Loosen et al. · 2022 · Biomedicines
Genistein Sensitizes Human Cholangiocarcinoma Cell Lines to Be Susceptible to Natural Killer Cells
Chutipa Chiawpanit, Suthida Panwong, Nunghathai Sawasdee, Pa‐thai Yenchitsomanus, Aussara Panya · 2022 · Biology
Phosphoproteomics reveals that cinobufotalin promotes intrahepatic cholangiocarcinoma cell apoptosis by activating the ATM/CHK2/p53 signaling pathway
Zhili Xia, Minzhen Li, Meng Xue Hu, Yanyan Lin, Lawrence Lawer Atteh, Wenkang Fu, Long Gao, Mingzhen Bai, Chongfei Huang, Ping Yue et al. · 2022 · Frontiers in Oncology
Comparison of laparoscopic and open pancreaticoduodenectomy for the treatment of distal cholangiocarcinoma: A propensity score matching analysis
Yuwen Zhu, Guangchen Zu, Di Wu, Yue Zhang, Yang Yang, Han Wu, Xuemin Chen, Weibo Chen · 2022 · Frontiers in Oncology
A novel prognostic system combining carbonic anhydrase II and preoperative CA19‐9 for intrahepatic cholangiocarcinoma after curative resection
Jiawei Zhang, Qiming Huang, Yi Yang, Jiahui Zhang, Xueting Fang, Yubin Yang, Huifang Liang, Wei Wang, Yanjun Wang · 2023 · Cancer
Management of locally advanced intrahepatic cholangiocarcinoma: a narrative review
Luke Bressler, Natalie M. Bath, Ashish Manne, Eric David Miller, Jordan M. Cloyd · 2023 · Chinese Clinical Oncology
Clinicopathological, etiological and molecular characteristics of intrahepatic cholangiocarcinoma subtypes classified by mucin production and immunohistochemical features
Yi Chen, Xiaoling Liu, Liyun Huang, Lihong Chen, Bin Wang · 2023 · Expert Review of Molecular Diagnostics
MCM6 promotes intrahepatic cholangiocarcinoma progression by upregulating E2F1 and enhancing epithelial–mesenchymal transition
Chongqing Gao, Jing Li, Fuling Zeng, Lijuan Wang, Kai‐Yun Chen, Dong Chen, Jian Hong, Chen Qu · 2023 · Carcinogenesis
SMAD4 regulates the progression of cholangiocarcinoma by modulating the expression of STING1
Anda Shi, Liming Zhao, Guo‐li Sheng, Ge‐ning Zhang, Yong‐chang Tang, Kangshuai Li, Zongli Zhang · 2023 · Journal of Cellular and Molecular Medicine
Exosomal circ_0037104 derived from Hu‐MSCs inhibits cholangiocarcinoma progression by sponging miR‐620 and targeting AFAP1
Zilin Yuan, Ba Xiong, Lie Liu, Yifan Lu, Yueping Liu, Gang Wang, Yang Qian, Bo Diao, Mingzhong Tu · 2024 · Journal of Biochemical and Molecular Toxicology
Is Repeat Resection for Recurrent Intrahepatic Cholangiocarcinoma Warranted? Outcomes of an International Analysis
Matthew L. Holzner, Vincenzo Mazzaferro, Michele Droz Dit Busset, Luca Antonio Aldrighetti, Francesca Ratti, Kiyoshi Hasegawa, Junichi Arita, Gonzalo Sapisochín, Phillipe Abreu, Wenzel Schöning et al. · 2024 · Annals of Surgical Oncology
Immunotherapy for the treatment of biliary tract cancer: an evolving landscape
Helen Catherine Wilbur, Nilofer Saba Azad · 2024 · Therapeutic Advances in Medical Oncology
High immune cell infiltration predicts improved survival in cholangiocarcinoma
Erkki‐Ville Wirta, Säde Szeto, Hanna Koppatz, Arno J. Nordin, Heikki Mäkisalo, Johanna T. Arola, Jukka Sirén, Maarit Ahtiainen, Jan Böhm, Jukka‐Pekka Mecklin et al. · 2024 · Frontiers in Oncology
Efficacy analysis of HAIC combined with lenvatinib plus PD-1 inhibitor vs. first-line systemic chemotherapy for advanced intrahepatic cholangiocarcinoma
Zhipeng Lin, Xugong Zou, Xiaolong Hu, Dabei Huang, Yuan Chen, Jiawen Lin, Xiaoqun Li, Jian Zhang · 2024 · Scientific Reports
FGFR2 fusions assessed by NGS, FISH, and immunohistochemistry in intrahepatic cholangiocarcinoma
Zi Cao, Yichen Yang, Shasha Liu, Lin Sun, Yanxue Liu, Ye Luo, Jian Wang, Yan Kui Sun · 2024 · Journal of Gastroenterology
The clinical value of Fibulin-1 for prognosis and its prospective mechanism in intrahepatic cholangiocarcinoma
Yusheng Jie, Jiao Gong, Cuicui Xiao, Jun Zheng, Zhiwei Zhang, Xinhua Li, Zhiliang Gao, Bo Hu, Yutian Chong · 2018 · HPB
Modern gastrointestinal endoscopic techniques for biliary tract cancers
Osman Ahmed, Jeffrey H. Lee · 2019 · Chinese Clinical Oncology
High expression of HVEM is associated with improved prognosis in intrahepatic cholangiocarcinoma
Bingqi Ma, Huijuan Meng, Ye Tian, Yingying Wang, Tianqiang Song, Ti Zhang, Qiang Wu, Yunlong Cui, Huikai Li, Wei Zhang et al. · 2020 · Oncology Letters
Nivolumab: an investigational agent for the treatment of biliary tract cancer
Alessandro Di Federico, Alessandro Rizzo, Angela Dalia Ricci, Giorgio Frega, Andrea Palloni, Simona Tavolari, Giovanni Brandi · 2020 · Expert Opinion on Investigational Drugs
A Novel Nomogram Based on Hepatic and Coagulation Function for Evaluating Outcomes of Intrahepatic Cholangiocarcinoma After Curative Hepatectomy: A Multi-Center Study of 653 Patients
Yunshi Cai, Bohan Zhang, Jiaxin Li, Hui Li, Hailing Liu, Kunlin Xie, Chengyou Du, Hong Mei Wu · 2021 · Frontiers in Oncology
Prognostic Value of Combined CA19-9 with Aspartate Aminotransferase to Lymphocyte Ratio in Patients with Intrahepatic Cholangiocarcinoma After Hepatectomy
Haizhou Qiu, Chang Xin Liu, Min Huang, Shu Yi Shen, Wentao Wang · 2021 · Cancer Management and Research
Screening a redox library identifies the anti-tumor drug Hinokitiol for treating intrahepatic cholangiocarcinoma
Peiying Bai, Ge Chen, Hui Yang, Haixu Chen, Lingfei Wan, Yuchen Zhang, Biao Zhang, Quan Zeng, Zeng Fan, Xuetao Pei et al. · 2022 · Frontiers in Bioscience-Landmark
Blockade of chloride channel-3 enhances cisplatin sensitivity of cholangiocarcinoma cells though inhibiting autophagy
Yanzhen Han, Yan Fang Zhou, Liyuan Zhou, Xiaoyan Jia, Xiangjun Yu, Xiaohong An, Zhe Shi · 2022 · Canadian Journal of Physiology and Pharmacology
ACOT12-mediated acetyl-CoA hydrolysis suppresses intrahepatic cholangiocarcinoma metastasis by inhibiting epithelial-mesenchymal transition
Xu Hui Zhou, Yujie Zhou, Weiqing Shao, Hong Liang, Ming‐De Lu, Wenwei Zhu · 2022 · Journal of Cancer
Cholangiocarcinoma: the quest for a second-line systemic treatment
Angélique Vienot, Cindy Neuzillet · 2019 · Translational Cancer Research
Case report: Conversion therapy for advanced intrahepatic cholangiocarcinoma using PD-1 inhibitor plus S-1 and nab-paclitaxel
Xiaocheng Li, Zhiyang Jiang, Yongjuan Wu, Wei Gong, Xiaofeng Liao, Xiaogang Li · 2022 · Frontiers in Oncology
Copper Increases the Sensitivity of Cholangiocarcinoma Cells to Tripterine by Inhibiting TMX2‐Mediated Unfolded Protein Reaction Activation
Hong‐Wen Liu, Lei Xu, Yiyang Zhang, Yiqiong Xie, Lishan Wang, Yue Zhou, Zhangding Wang, Yani Pan, Wenying Li, Lu Xu et al. · 2023 · Advanced Healthcare Materials
Trends in mortality of liver cancer before and during the COVID ‐19 pandemic, 2017–2021
Donghee Kim, Richie Manikat, George T. Cholankeril, Aijaz Ahmed · 2023 · Liver International
Evaluation of potential targets to enhance the sensitivity of cholangiocarcinoma cells to anticancer drugs
Paula Sanchon-Sanchez, Óscar Briz, Rocı́o I.R. Macı́as, M. Abad, Anabel Sánchez-Martín, José J.G. Marı́n, Elisa Lozano · 2023 · Biomedicine & Pharmacotherapy
Attachment preferences of Hyalomma truncatum and Hyalomma marginatum rufipes ticks (Acari: Ixodidae) on two sheep breeds.
Leon J. Fourie, Dawid J. Kok · 1995 · PubMed
CT-based Radiomics for Biliary Tract Cancer: A Possible Solution for Predicting Lymph Node Metastases
Andrea Laghi, Cecilia Voena · 2018 · Radiology
Key challenges for drugs in clinical development for cholangiocarcinoma
Bridget P. Keenan, Robin Kate Kelley · 2021 · Expert Opinion on Investigational Drugs
Prognosis prediction and comparison between pancreatic signet ring cell carcinoma and pancreatic duct adenocarcinoma: a retrospective observational study
Hui Zhou, Xiaoxue Li, Yun-peng Huang, Yongxiang Wang, Heng Zou, Li Xiong, Zhongtao Liu, Yu Wen, Zijian Zhang · 2023 · Frontiers in Endocrinology
Effect of the Home to Hospital to Home nutrition management program on postoperative liver cancer patients: A single-center randomized controlled study
Runan Zhao, Xiaohong Hou, Yushuo Niu, Jianlu Wang · 2023 · Medicine
Integration of circulating tumor DNA in biliary tract cancer: the emerging landscape
Joy A. Awosika, Cecilia Monge, Tim F. Greten · 2024 · Hepatic Oncology
Improving Recurrence Prediction in Intrahepatic Cholangiocarcinoma: The Synergistic Impact of the FIB-4 Index and Tumor Burden Score on Post-hepatectomy Outcomes
Miho Akabane, Jun Kawashima, Selamawit Woldesenbet, Amanda B. Macedo, François Cauchy, Feng Shen, Shishir Kumar Maithel, Bas Groot Koerkamp, Sorin Tiberiu Alexandrescu, Minoru Kitago et al. · 2024 · Annals of Surgical Oncology
CDK4/6 inhibitors upregulate cIAP1/2, and Smac mimetic LCL161 enhances their antitumor effects in cholangiocarcinoma cells
Pimchanok Menapree, Nattaya Duangthim, Apiwit Sae-Fung, Sasiprapa Sonkaew, Siriporn Jitkaew · 2025 · Scientific Reports
Epidemiology and genomic features of biliary tract cancer and its unique features in Korea
Seonjeong Woo, Youngun Kim, Sohyun Hwang, Hong Jae Chon · 2025 · Journal of Liver Cancer
A Novel Nomogram Based on Log Odds of Metastatic Lymph Nodes to Predict Overall Survival in Patients With Perihilar Cholangiocarcinoma After Surgery
Wenbo Zou, Chunyu Zhu, Zizheng Wang, Tan X, Chenggang Li, Zhiming Zhao, Minggen Hu, Rong Liu · 2021 · Frontiers in Oncology
Helicobacter pylori GroEL Seropositivity Is Associated with an Increased Risk of Opisthorchis viverrini-Associated Hepatobiliary Abnormalities and Cholangiocarcinoma
Isabelle Jala, Muhammad Luthfi Almanfaluthi, Thewarach Laha, Sakawrat Kanthawong, Sirikachorn Tangkawattana, Prasert Saichua, Sutas Suttiprapa, Banchob Sripa · 2021 · Korean Journal of Parasitology
Knockdown of PSMC2 contributes to suppression of cholangiocarcinoma development by regulating CDK1
Xiaohui Duan, Jianhui Yang, Bo Jiang, Wenbin Duan, Rongguang Wei, Hui Zhang, Xianhai Mao · 2021 · Aging
Selected by bioinformatics and molecular docking analysis, Dhea and 2–14,15-Eg are effective against cholangiocarcinoma
Lei Qin, Jun Kuai, Fang Yang, Yang Lu, Peisheng Sun, Lanfang Zhang, Guangpeng Li · 2022 · PLoS ONE
The Role of Immunosuppression for Recurrent Cholangiocellular Carcinoma after Liver Transplantation
Safak Gül‐Klein, Paulina Schmitz, Wenzel Schöning, Robert Öllinger, Georg Lurje, Sven Jonas, Deniz Uluk, Uwe Pelzer, Frank Tacke, Moritz Schmelzle et al. · 2022 · Cancers
The predictive value of lymphocyte to monocyte ratio for overall survival in cholangiocarcinoma patients with hepatic resection
Minghe Lv, Kun Wang, Zhiyuan Zhang, Zhen Zhang, Juefeng Wan · 2023 · Cancer Medicine
Predictive Factors for Post-Hepatectomy Liver Failure in Patients with Cholangiocarcinoma
Wanthiwa Kriengkrai, Busaba Somjaivong, Attapol Titapun, Parichat Wonggom · 2023 · Asian Pacific Journal of Cancer Prevention
Characteristic Analysis of Featured Genes Associated with Cholangiocarcinoma Progression
Qigu Yao, Wenyi Chen, Feiqiong Gao, Yuchen Wu, Lingling Zhou, Haoying Xu, Jong Yu, Xinli Zhu, Lan Wang, Lanjuan Li et al. · 2023 · Biomedicines
Effect of Tacrolimus Time in Therapeutic Range on Postoperative Recurrence in Patients Undergoing Liver Transplantation for Liver Cancer
Qianying Lao, Xuanyu Wu, Xinxin Zheng, Jinwei Hu, Siqi Huang, Danying Li, Yao Du, Na Yang, Huaijun Zhu · 2023 · Therapeutic Drug Monitoring
Degradation of AZGP1 suppresses apoptosis and facilitates cholangiocarcinoma tumorigenesis via TRIM25
Hyeseon Yun, Hong-Rae Jeong, Do Yeon Kim, Ji‐Eun You, Ji‐U Lee, Dong‐Hee Kang, Dong‐In Koh, Yea Seong Ryu, Seunggeon Bae, Dong‐Hoon Jin · 2024 · Journal of Cellular and Molecular Medicine
Oncogenic Roles of Laminin Subunit Gamma‐2 in Intrahepatic Cholangiocarcinoma via Promoting EGFR Translation
Jianjuan Zhang, Fubo Ji, Yaqi Tan, Lei Zhao, Yongzhi Zhao, Jiaxin Liu, Liyuan Shao, Jiong Shi, Meihua Ye, Xianglei He et al. · 2024 · Advanced Science
Application of dynamic contrast enhanced ultrasound analysis in predicting early response to systemic therapy of intrahepatic cholangiocarcinoma
Xiu-Yun Lu, Jun Jiang, Sheng Chen, Yijie Qiu, Ying Wang, Juan Cheng, Xinliang Xu, Yi Dong, Wen‐Ping Wang · 2024 · European Journal of Radiology
Medical imaging-based companion diagnostics for solid tumors
Rui Yin, Qingpeng Zhang, Shiyi Liao, Chang Lu, Cheng Zhang, Qingyun Cai, Guosheng Song · 2024 · EngMedicine
Real-world outcomes of chemotherapy plus immune checkpoint inhibitors versus chemotherapy alone in advanced, unresectable, and recurrent intrahepatic cholangiocarcinoma
Tinotenda Blessing Madzikatire, Shan Heng, Hongyi Gu, Yunfeng Shan, En-Hua Lin, Joshua Banda, Asta Debora, Brandon Anotida Madziva, Mutale Jaeste Bowa, Munyaradzi Godfrey Mudhuri et al. · 2024 · Frontiers in Immunology
Identification of whole-genome mutations and structural variations of bile cell-free DNA in cholangiocarcinoma
Lei Yin, Anqi Duan, Wei Zhang, Bin Li, Teng Zhao, Xiaoya Xu, Lixue Yang, Baoning Nian, Kai Lu, Sheng Chen et al. · 2024 · Genomics
HSF1 is a prognostic determinant and therapeutic target in intrahepatic cholangiocarcinoma
Antonio Cigliano, Isabella Gigante, Marina Serra, Gianpaolo Vidili, Maria Maddalena Simile, Sara Martina Steinmann, Francesco Urigo, Eleonora Cossu, Giovanni Mario Pes, Maria Pina Dore et al. · 2024 · Journal of Experimental & Clinical Cancer Research
N-acetyltransferase 10 affects the proliferation of intrahepatic cholangiocarcinoma and M2-type polarization of macrophages by regulating C-C motif chemokine ligand 2
Teng Cai, Jianye Dai, Yanyan Lin, Zhongtian Bai, Jingdong Li, Wenbo Meng · 2024 · Journal of Translational Medicine
Whole exome sequencing of multi-regions reveals tumor heterogeneity in Opisthorchis viverrini-associated cholangiocarcinoma
Sirinya Sitthirak, Arporn Wangwiwatsin, Apinya Jusakul, Nisana Namwat, Poramate Klanrit, Hasaya Dokduang, Prakasit Sa-Ngiamwibool, Attapol Titapun, Apiwat Jareanrat, Vasin Thanasukarn et al. · 2025 · Scientific Reports
Combined treatment of cholangiocarcinoma with interventional radiofrequency hyperthermia and heat shock protein promoter-mediated HSV-TK gene therapy.
Jingfeng Luo, Jiali Zhou, Fengnan Xie, Yali Zhu, Fei Zhou, Shuanglin Zhang, Shaojie Jiang, Jie He, Jiaxin Liu, Xia Wu et al. · 2018 · Europe PMC (PubMed Central)
A novel prognostic nomogram for patients with surgically resected perihilar cholangiocarcinoma: a SEER-based study
Pengfei Li, Lujun Song · 2021 · Annals of Translational Medicine
Targeted therapies for extrahepatic cholangiocarcinoma: preclinical and clinical development and prospects for the clinic
Massimiliano Cadamuro, Alberto Lasagni, Ángela Lamarca, Laura Fouassier, Maria Guido, Samantha Sarcognato, Enrico Gringeri, Umberto Cillo, Mario Strazzabosco, José J.G. Marı́n et al. · 2021 · Expert Opinion on Investigational Drugs
Long Non-coding RNA SNHG12, a New Therapeutic Target, Regulates miR-199a-5p/Klotho to Promote the Growth and Metastasis of Intrahepatic Cholangiocarcinoma Cells
Hongguo Yang, Tianpeng Wang, Sheng’an Hu, Chaozhou Hu, Cheng-hang Jiang, Qiang He · 2021 · Frontiers in Medicine · Retracted
Liver Transplantation for Unresectable Intrahepatic Cholangiocarcinoma: The Role of Sequencing Genetic Profiling
Salvatore Gruttadauria, Floriana Barbera, Duilio Pagano, Rosa Liotta, Roberto Miraglia, Marco Barbàra, Maria Grazia Bavetta, Calogero Cammà, Ioannis Petridis, Daniele Di Carlo et al. · 2021 · Cancers
Ivosidenib for IDH1 Mutant Cholangiocarcinoma: A Narrative Review
Vikram Sumbly, Ian Landry, Vincent Rizzo · 2022 · Cureus
Glycosylation of FGFR4 in cholangiocarcinoma regulates receptor processing and cancer signaling
A. Phillips, M. Lobl, Y. Hafeji, Hannah R. Safranek, Ashley M. Mohr, J. Mott · 2022 · Journal of Cellular Biochemistry
Silibinin Therapy Improves Cholangiocarcinoma Outcomes by Regulating ERK/Mitochondrial Pathway
Yang Bai, Jiaqi Chen, Weijian Hu, Lei Wang, Yulian Wu, Shian Yu · 2022 · Frontiers in Pharmacology
Intensive Follow-Up Program and Oncological Outcomes of Biliary Tract Cancer Patients after Curative-Intent Surgery: A Twenty-Year Experience in a Single Tertiary Medical Center
Alessandro Rizzo, Riccardo Carloni, Giorgio Frega, Andrea Palloni, Alessandro Di Federico, Angela Dalia Ricci, Raffaele De Luca, Simona Tavolari, Giovanni Brandi · 2022 · Current Oncology
The therapeutic effect of KSP inhibitors in preclinical models of cholangiocarcinoma
Yuanyuan Shi, Xiaowen Cui, Tianyi Jiang, Yufei Pan, Yun‐Kai Lin, Xiaofan Feng, Zhiwen Ding, Chun Yang, Yexiong Tan, Hongyang Wang et al. · 2022 · Cell Death and Disease
Targeting BRCA‐mutant biliary tract cancer: Current evidence and future perspectives
Xin Yu Li, Jia Qi Chen, Adilai Aisa, Yu Wei Ding, Ding Zhang, Ying Yuan · 2023 · Journal of Digestive Diseases
Safety and feasibility of laparoscopic liver resection for intrahepatic cholangiocarcinoma: a propensity score-matched study
Zefeng Shen, Liye Tao, Jingwei Cai, Junhao Zheng, Yubin Sheng, Zaibo Yang, Linghan Gong, Chao Song, Jiaqi Gao, Hanning Ying et al. · 2023 · World Journal of Surgical Oncology
LAMC2 is a potential prognostic biomarker for cholangiocarcinoma
Khaa Hoo Ong, Yao‐Yu Hsieh, Hong-Yue Lai, Ding‐Ping Sun, Tzu‐Ju Chen, Steven K. Huang, Yufeng Tian, Chia-Lin Chou, Yow‐Ling Shiue, Hung‐Chang Wu et al. · 2023 · Oncology Letters
Identification of chondroitin polymerizing factor (CHPF) as tumor promotor in cholangiocarcinoma through regulating cell proliferation, cell apoptosis and cell migration
Xiaohui Duan, Jianhui Yang, Bo Jiang, Wenbin Duan, Rongguang Wei, Hui Zhang, Xianhai Mao · 2021 · Cell Cycle
Should all intrahepatic cholangiocarcinomas receive neoadjuvant chemotherapy before resection?
Hauke Lang · 2021 · British journal of surgery
Novel biomarkers for cholangiocarcinoma: how can it enhance diagnosis, prognostication, and investigational drugs? Part-1
Ranuka Sinniah, Mark A. Shapses, Mohammad Umar Ahmed, Hani M. Babiker, Sreenivasa Rao Chandana · 2021 · Expert Opinion on Investigational Drugs
Identification of hub genes and pathways in cholangiocarcinoma by coexpression analysis
Junjie Kong, Shu Yi Shen, Zifei Zhang, Wentao Wang · 2020 · Cancer Biomarkers
Clinical research progress of targeted therapy combined with immunotherapy for advanced cholangiocarcinoma
Qin Liu, Yuanyuan Chen, Yan Hu, Jiyuan Yang · 2023 · Cancer Treatment and Research Communications
O ‑GlcNAcylation Facilitates the Interaction between Keratin 18 and Isocitrate Dehydrogenases and Potentially Influencing Cholangiocarcinoma Progression
Xiangfeng Meng, Yue Zhou, Lei Xu, Limu Hu, Changjiang Wang, Xiao Tian, Xiang Zhang, Yi Hao, Bo Cheng, Jing Ma et al. · 2024 · ACS Central Science
CT-based radiogenomics of intrahepatic cholangiocarcinoma
Luca Viganò, Valentina Zanuso, Francesco Fiz, Luca Cerri, Maria Elena Laino, Angela Ammirabile, Elisa Maria Ragaini, Samuele Viganò, Luigi Terracciano, Marco Francone et al. · 2024 · Digestive and Liver Disease
Efficacy and safety of camrelizumab, apatinib, and capecitabine combination therapy in advanced biliary tract cancer: a phase 2, nonrandomized, prospective study
Chao Jing, Zhigang Bai, Kuinan Tong, Xiaobao Yang, Kun Liu, Hongwei Wu, Jiegao Zhu, Wei Guo, Zhongtao Zhang, Wei Deng · 2024 · The Oncologist
Real-world efficacy of immune checkpoint inhibitors in microsatellite unstable/mismatch repair-deficient biliary tract cancer: An AGEO study
I. Campo le Brun, Emma Grapinet, Valérie Aurillac, Antoine Hollebecque, Pauline Parent, Paul Girot, David Tougeron, Mélanie Gendreau, Brice Chanez, Eric Assénat et al. · 2025 · European Journal of Cancer
Anti-PD1 antibody toripalimab combined with lenvatinib, or GEMOX chemotherapy combined with lenvatinib as first-line therapy in patients with advanced intrahepatic cholangiocarcinoma: a randomized, open, two-cohort Phase 2 Study
Xiaoyong Huang, Guo‐Ming Shi, Zhitao Zheng, Hui‐Chuan Sun, Fei Liang, Yuan Ji, Yi Chen, Guo‐Huan Yang, Zhiqiang Hu, Jia‐Cheng Lu et al. · 2025 · BMC Medicine